Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation

被引：0
|
作者：
Geeta Hampson
机构：
[1] Guy’s and St Thomas’ NHS Foundation Trust,Department of Chemical Pathology/Metabolic Bone Clinic
来源：
Calcified Tissue International | 2011年 / 88卷
关键词：
Osteoporosis; Bone Formation; Bisphosphonates; Teriparatide; Postmenopausal Osteoporosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease
    Parker, V. J.
    Harjes, L. M.
    Dembek, K.
    Young, G. S.
    Chew, D. J.
    Toribio, R. E.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2017, 31 (03) : 791 - 798
  • [22] (1-34) Parathyroid Hormone Infusion Acutely Lowers Fibroblast Growth Factor 23 Concentrations in Adult Volunteers
    Gutierrez, Orlando M.
    Smith, Kelsey T.
    Barchi-Chung, Allison
    Patel, Neha M.
    Isakova, Tamara
    Wolf, Myles
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (01): : 139 - 145
  • [23] Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men
    Marsell, Richard
    Grundberg, Elin
    Krajisnik, Tijana
    Mallmin, Hans
    Karlsson, Magnus
    Mellstrom, Dan
    Orwoll, Eric
    Ohlsson, Claes
    Jonsson, Kenneth B.
    Ljunggren, Osten
    Larsson, Tobias E.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 158 (01) : 125 - 129
  • [24] Parathyroid hormone (hPTH 1-34) and estrogen dramatically increases bone density in postmenopausal osteoporosis: A placebo-controlled randomized trial
    Roe, EB
    Cann, CF
    Sanchez, SD
    Bachetti, P
    Black, D
    Arnaud, CD
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S196 - S197
  • [25] Oral Phosphorus Supplementation Secondarily Increases Circulating Fibroblast Growth Factor 23 Levels at Least Partially via Stimulation of Parathyroid Hormone Secretion
    Takasugi, Satoshi
    Akutsu, Miho
    Nagata, Masashi
    JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY, 2014, 60 (02) : 140 - 144
  • [26] FIBROBLAST GROWTH FACTOR-23 AND PARATHYROID HORMONE PREDICT THE EXTENT OF AORTIC VALVE CALCIFICATIONS IN PATIENTS WITH CHRONIC KIDNEY DISEASE NOT ON DIALYSIS
    Di Lullo, Luca
    Russo, Domenico
    Gorini, Antonio
    Ronco, Claudo
    Santoboni, Alberto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [27] Effects of Intermittent Parathyroid Hormone 1-34 Administration on Circulating Mesenchymal Stem Cells in Postmenopausal Osteoporotic Women
    Tang, Yutao
    Xia, Han
    Kang, Liang
    Sun, Quan
    Su, Zhe
    Hao, Congqiang
    Xue, Yuan
    MEDICAL SCIENCE MONITOR, 2019, 25 : 259 - 268
  • [28] Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
    Neer, RM
    Arnaud, CD
    Zanchetta, JR
    Prince, R
    Gaich, GA
    Reginster, JY
    Hodsman, AB
    Eriksen, EF
    Ish-Shalom, S
    Genant, HK
    Wang, OH
    Mitlak, BH
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (19): : 1434 - 1441
  • [29] Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis
    Zanchetta, JR
    Bogado, CE
    Ferretti, JL
    Wang, O
    Wilson, MG
    Sato, M
    Gaich, GA
    Dalsky, GP
    Myers, SL
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (03) : 539 - 543
  • [30] Association of Circulating Fibroblast Growth Factor-23 with Renal Phosphate Excretion among Hemodialysis Patients with Residual Renal Function
    Wang, Mengjing
    You, Li
    Li, Haiming
    Lin, Yong
    Zhang, Zhijie
    Hao, Chuanming
    Chen, Jing
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (01): : 116 - 125
12345